Delisting risk
KALA · NASDAQ · Biotechnology

KALA BIO

Evaluates biotech AI infrastructure while preserving biologics assets for potential partners.

$0.6902
After-hours close+0.00 (+0.01%)
At close$0.6901(−15.02%)
DateEstimateReportedSurprise
Nov 2026−$6.00
Aug 2026−$6.00−$21.32−255.3%
May 2026−$8.50−$0.20+97.6%
Apr 2026−$16.00$0.08+100.5%
Nov 2025−$1.01−$1.07−5.9%

The latest year is open to everyone — the 39 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Nov 2020
Aug 2020
May 2020
Feb 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
Mar 2017
Dec 2016
Sep 2016
Jun 2016
Mar 2016
Dec 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 10, 2026−$6.00
Aug 19, 2026−$6.00−$21.32−255.3%$25.0M
May 15, 2026−$8.50−$0.20+97.6%
Apr 15, 2026−$16.00$0.08+100.5%
Nov 19, 2025−$1.01−$1.07−5.9%

The latest year is open to everyone — the 39 quarters behind it read with an account.

Sign in
Aug 8, 2025
May 14, 2025
Mar 31, 2025
Nov 12, 2024
Aug 6, 2024
May 14, 2024
Mar 29, 2024
Nov 13, 2023
Aug 4, 2023
May 9, 2023
Mar 3, 2023
Nov 8, 2022
Aug 11, 2022
May 16, 2022
Mar 29, 2022
Nov 15, 2021
Aug 5, 2021
May 5, 2021
Feb 25, 2021
Nov 5, 2020
Aug 6, 2020
May 7, 2020
Feb 12, 2020
Nov 7, 2019
Aug 6, 2019
May 9, 2019
Mar 11, 2019
Nov 8, 2018
Aug 9, 2018
May 10, 2018
Mar 26, 2018
Nov 7, 2017
Aug 31, 2017
Mar 31, 2017
Dec 31, 2016
Sep 30, 2016
Jun 30, 2016
Mar 31, 2016
Dec 31, 2015